Home > Financial Ratios > TRIDENT LIFELINE

TRIDENT LIFELINE
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for TRIDENT LIFELINE
Please provide your vote to see the results

TRIDENT LIFELINE Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 38.82124.29-

What is the latest Core EBITDA Growth ratio of TRIDENT LIFELINE ?

The latest Core EBITDA Growth ratio of TRIDENT LIFELINE is 38.82 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202438.82
Mar2023124.29
Mar2022-

How is Core EBITDA Growth of TRIDENT LIFELINE Trending?

Years Core EBITDA Growth % Change
Mar2024 38.82
-68.77
Mar2023 124.29
0
Mar2022 0 -

Other Financial Ratios of TRIDENT LIFELINE


Compare Core EBITDA Growth ratio of peers of TRIDENT LIFELINE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TRIDENT LIFELINE ₹286.9 Cr 4.9% -4.9% 33.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,213.0 Cr 4.7% -5.4% 0.5% Stock Analytics
DIVIS LABORATORIES ₹150,403.0 Cr 0.5% -9.8% 55.5% Stock Analytics
CIPLA ₹117,415.0 Cr 2% -1.8% -1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹104,791.0 Cr 2.6% -6.1% 14% Stock Analytics
DR REDDYS LABORATORIES ₹92,228.2 Cr -0.9% -10% -11.3% Stock Analytics


TRIDENT LIFELINE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TRIDENT LIFELINE

4.9%

-4.9%

33.5%

SENSEX

0.4%

-4.9%

-0.1%


You may also like the below Video Courses